5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
Clinical trial NCT05385549 · RECRUITING
Trial details
- NCT number
- NCT05385549
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2030-04-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.